New Insight into the SAR of Pyrimido [4,5-b][1,4] Benzothiazines as 15-lipoxygenase Inhibitors

Document Type: Original Article

Authors

1 1Department of Chemistry, Mashhad Branch, Islamic Azad University, Mashhad, IR Iran

2 Department of Chemistry, School of Sciences, Ferdowsi University of Mashhad, Mashhad, 917751436, IR Iran

3 Student Research Committee, Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, IR Iran

4 2Department of Chemistry, School of Sciences, Ferdowsi University of Mashhad, Mashhad, 917751436, IR Iran

5 Antimicrobial Resistance Research Center, Mashhad University of Medical Sciences, Mashhad 91967-73117, IR Iran 5 Department of Laboratory Sciences, School of Paramedical Sciences, Mashhad University of Medical Sciences, Mashhad, IR Iran

Abstract

 

Objective(s): Recently we reported that the soybean 15-lipoxygenase (SLO) inhibitory activity of pyrimido[4,5-b][l,4]benzothiazines largely depends on the orientation of sulfur atom of thiazine core towards FeIII-OH in the active site pocket of the enzyme with subsequent oxidation of sulfur to sulfoxide. In this paper the results of a comparative study on the SLO inhibitory activities of the mentioned compounds using ab initio calculations and docking analyses has been reported.
Materials and Methods:
Structure optimization and docking analyses were performed using HyperChem 7.5 and AutoDock Tools 4.0 respectively. Enzyme assessment was reduced using spectrophotometric MBTH-DMAB method.
Results
 
: The inhibitory activity of synthetic 2-substituted pyrimido[4,5-b][l,4]benzothiazines against soybean 15-lipoxygenase (SLO) was evaluated and structure activity relationships and binding modes of their 4-H and 4-methyl analogs were studied using docking analysis and ab initio calculations.
Discussion:
The results of these studies showed that the lack of 4-methyl substituent in the pyrimido[4,5-b][1,4]benzothiazine molecules greatly reduces their lipoxygenase inhibitory activities and it was also found that the HOMO energy difference between the 4-H and 4-Methyl analogs can be responsible for the observed inhibitory activity reduction.
Conclusion:
Our molecular modeling studies shows that by using more flexible amino acids during the docking process, more rational results can be obtained. The method of measuring the lipoxygenase activity is also of prime importance for the study of structure activity relationship.

Keywords


 

1. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999; 274:23679-23682.

2. Kuhn H, Thiele BJ. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 1999; 449:7-11.

3. Larsen JS, Acosta EP. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma. Ann Pharmacother 1993; 27:898-903.

4. Schewe T. 15-Lipoxygenase-1: a prooxidant enzyme. Biol Chem 2002; 383:365-374.

5. Kelavkar U, Glasgow W, Eling TE. The effect of 15- lipoxygenase-1 expression on cancer cells. Curr Urol Rep 2002; 3:207-214.

6. Kelavkar UP, Cohen C, Kamitani H, Eling TE, Badr KF. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis 2000; 21:1777-1787.

7. Zhu J, Kilty I, Granger H, Gamble E, Qiu YS, Hattotuwa K, et al. Gene expression and immunolocalization of 15-lipoxygenase isozymes in the

SAR of Pyrimidobenzothiazines as 15-LO Inhibitors

Samareh Fekri M et al

Iran J Basic Med Sci, Vol. 16, No. 6, Jun 2013

 

789

 

airway mucosa of smokers with chronic bronchitis. Am J Respir Cell Mol Biol 2002; 27:666-677.

8. Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 2004; 14:191-195.

9. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, et al. Funk CD. Distruption of the12/15- Lipoxygenase gene diminishes atherosclerosis in Apo E-deficient mice. J Clin Invest 1999; 103:1597-1604.

10. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, et al. Overexpression of 15-Lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL reseptor-deficient mice. Arterioscler Thromb Vasc Biol 2002; 20:2100-2105.

11. Sultana C, Shen Y, Rattan V. Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. Cell Phys 1996; 167:477-487.

12. Setty BN, Werner MH, Annun YA, Stuart MJ. 15-hydroxyeicosatetraenoic acid –mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol-1,4,5-trisphosphate. Blood 1992; 80:2765-2773.

13. Charlier C, Michaux C. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-Lipoxygenase (5-LOX) as a new start to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 2003; 38:645-659.

14. Bakavoli M, Nikpour M, Rahimizadeh M, Saberi MR, Sadeghian H. Design and synthesis of pyrimido[4,5-e][1,3,4] thiadiazine derivatives as potent 15-Lipoxygenase inhibitors. Bioorg Med Chem 2007; 15:2120-2126.

15. Bakavoli M, Sadeghian H, Tabatabaei Z, Rahimizadeh M, Nikpour M. SAR comparative studies on pyrimido[4,5-b][1,4]benzothiazine derivatives as 15- Lipoxygenase inhibitors using ab initio calculations. J Mol Model 2008; 14:471-476.

16. Jabbari A, Davoodnejad M, Alimardani M, Assadieskandar A, Sadeghian A, Safdari H, et al. Synthesis and SAR Studies of 3-Allyl-4-prenyloxyaniline Amides as Potent 15-Lipoxygenase Inhibitors. Bioorg Med Chem 2012; 20:5518-5526.

17. Caballero J, Fernandez M, Coll D. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA. Chem Biol Drug Des 2010; 76:511-517.

18. Sadeghian H, Seyedi SM, Saberi MR, Arghiani Z. Design and synthesise of eugenol derivatives, as potent 15- Lipoxygenase inhibitors. Bioorg Med Chem 2008; 16:890-901.

19. Sadeghian H, Attaran N, Jafari Z, Saberi MR, Pordel M, Riazi M. Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem 2009; 17:2327-2335.

20. ChemDraw® Ultra, Chemical Structure Drawing Standard, Cambridge Soft Corporation, 100 Cambridge Park Drive, Cambridge, MA 02140 USA. Available at: http://www. Cambridgesoft.com

21. HyperChem® Release 7, Hypercube Inc. Available at: http://www.hyper.com/

22. Auto Dock Tools (ADT), the Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037-1000, USA. Available at:http://www.scripps.edu/pub/olson-web/doc/autodock/.

23. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated Docking using a Lamarckian Genetic Algorithm and an Empirical binding free energy function. J Comput Chem 1998; 19:1639-1662.

24. Sippl WJ. Receptor-based 3D QSAR analysis of estrogen receptor ligands-merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods. J Comput Aided Mol Des 2000; 14:559-572.

25. Iranshahi M, Jabbari A, Orafaie A, Mehri R, Zeraatkar S, Ahmadi T, Alimardani M, Sadeghian H, Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors. Eur J Med Chem 2012; 57:134-142.

26. Huey R, Morris GM. Auto Dock Tools; A Tutorial, 2006, 10550 North Torrey pines Road, CA92037-1000, USA.

27. http://www.accelrys.com/products/discovery-studio